NCT00374582View on ClinicalTrials.gov

End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
End Stage Liver Disease
Interventions
DEVICE

Bodystat Quadscan 4000

device determining body composition and nutritional status

DEVICE

bodystat quadscan 400

device determining body composition and nutritional status

Trial Locations (1)

45267

University of Cincinnati, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER

NCT00374582 - End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA) | Biotech Hunter | Biotech Hunter